Novo Nordisk’s Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts January 27, 2022 Auto Bot News 0 Novo Nordisk’s Wegovy, hamstrung by Catalent FDA write-up, could correct course by mid-2022: analysts fkansteiner Thu, 01/27/2022 – 08:24
